Search Results 871-880 of 16657 for praluent side afects

  1. Oncology (Medical) - Clinical trials

    The study is looking at several other research questions, including: * What side effects may happen from taking the study drug and its experimental ...

  2. Hematology - Clinical trials

    This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

  3. Joel Streed | Mayo Clinic News Network - Page 83 of 170

    Common side effects of cancer treatment can include nausea, vomiting, fatigue and weight loss. These side effects make getting proper nutrition a challenge. To ...

  4. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as alemtuzumab, can bind to and kill malignant lymphocytes. PURPOSE: This phase I/II trial is studying the side effects and best ...

  5. Cancer Clinical Trials - Medical Professionals

    Rochester, Minn. The purpose of this study is to find out more about the side effects of the CAR-T therapy called IC19/1563 and what dose of ...

  6. A Study Using Clofarabine and Cytarabine in Treating Children with Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia - Mayo Clinic

    Giving more than one drug (combination chemotherapy) may kill more cancer cells. The purpose of this trial is studying the side effects and best dose of ...

  7. Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer - Mayo Clinic

    About this study. This phase I trial studies the side effects and best dose of olaparib and onalespib when given together in treating patients with solid tumors ...

  8. Clinical trials - Oncology (Medical)

    This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

  9. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    About this study. This phase I/II trial studies the best dose and side effects of anetumab ravtansine when given together with atezolizumab and how well ...

  10. A Study to Evaluate Pevonedistat, Azacitidine (or Decitabine), and Venetoclax (PAVE) to Treat Acute Myelogenous Leukemia (AML) Patients - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...